Kyoto, Japan

Takeshi Shiota

USPTO Granted Patents = 4 

 

 

Average Co-Inventor Count = 4.0

ph-index = 3

Forward Citations = 115(Granted Patents)


Location History:

  • Kyoto, JP (1994)
  • Osaka, JP (2006 - 2009)

Company Filing History:


Years Active: 1994-2009

Loading Chart...
Loading Chart...
Loading Chart...
4 patents (USPTO):Explore Patents

Title: Innovations by Takeshi Shiota: Pioneering Anti-Inflammatory Compounds

Introduction

Takeshi Shiota is a prominent inventor based in Kyoto, Japan, recognized for his contributions to the field of pharmaceuticals. With a total of two patents to his name, Shiota is making significant strides in the development of novel compounds that address critical health issues.

Latest Patents

His most recent patent focuses on "3-benzylidene-1-carbamoyl-2-pyrrolidone" analogues, which exhibit notable anti-inflammatory properties. This invention presents a new formula that is aimed at treating chronic inflammation with minimal side effects, such as gastrointestinal complications. The structural details of the compound point to varied functional groups that enhance its efficacy as a therapeutic agent.

Career Highlights

Takeshi Shiota has made remarkable advancements while working at Shionogi Seiyaku Kabushiki Kaisha, a leading pharmaceutical company. His work not only underscores his dedication to developing effective anti-inflammatory solutions but also showcases his innovative approach to tackling complex medical challenges.

Collaborations

In his journey, Shiota has collaborated with talented colleagues such as Susumu Kamata and Nobuhiro Haga. These collaborations have enriched his research and development endeavors, allowing for a multidisciplinary approach in creating effective pharmaceutical products.

Conclusion

In summary, Takeshi Shiota is a noteworthy inventor whose work on anti-inflammatory compounds holds promise for improving patient outcomes. His contributions reflect not only his innovative spirit but also the collaborative efforts within the pharmaceutical industry, paving the way for new treatments that prioritize patient safety and efficacy.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…